Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,760.00
-1,000.00 (-9.29%)
At close: Apr 2, 2026

KOSDAQ:014950 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23
90,493128,125--
Enterprise Value
61,441108,749--
Last Close Price
9840.0013970.00--
PS Ratio
1.512.13--
PB Ratio
1.311.86--
P/TBV Ratio
1.321.87--
P/OCF Ratio
43.5861.70--
EV/Sales Ratio
1.021.81--
EV/EBITDA Ratio
13.2223.39--
EV/EBIT Ratio
18.7733.23--
Debt / Equity Ratio
0.040.040.000.00
Debt / EBITDA Ratio
0.650.650.020.05
Debt / FCF Ratio
--0.030.23
Net Debt / Equity Ratio
-0.42-0.42-0.25-0.18
Net Debt / EBITDA Ratio
-6.25-6.25-2.55-2.10
Net Debt / FCF Ratio
21.5821.58-3.62-9.80
Asset Turnover
0.800.800.91-
Inventory Turnover
1.311.311.56-
Quick Ratio
3.513.512.092.03
Current Ratio
4.854.853.273.23
Return on Equity (ROE)
-1.25%-1.25%7.02%-
Return on Assets (ROA)
2.74%2.74%3.73%-
Return on Invested Capital (ROIC)
-135.99%-128.85%7.55%6.10%
Return on Capital Employed (ROCE)
4.50%4.50%6.80%5.60%
Earnings Yield
-0.83%-0.59%--
FCF Yield
-1.49%-1.05%--
Payout Ratio
--7.98%4.73%
Buyback Yield / Dilution
-8.46%-8.46%-0.15%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.